SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001140361-20-016369
Filing Date
2020-07-20
Accepted
2020-07-20 09:21:36
Documents
15

Document Format Files

Seq Description Document Type Size
1 424B5 nt10013010x5_424b5.htm 424B5 687052
2 logo_inflarx.jpg GRAPHIC 29996
3 logo_inflarxx1.jpg GRAPHIC 27642
4 nt10013010x5_barchart01.jpg GRAPHIC 138001
5 nt10013010x5_barchart02.jpg GRAPHIC 168415
6 nt10013010x5_barchart03.jpg GRAPHIC 135999
7 nt10013010x5_barchart04.jpg GRAPHIC 162315
8 nt10013010x5_flowchart01.jpg GRAPHIC 103598
9 nt10013010x5_flowchart02.jpg GRAPHIC 104950
10 nt10013010x5_linechart01.jpg GRAPHIC 153118
11 nt10013010x5_linechart02.jpg GRAPHIC 179819
12 nt10013010x5_linechart03.jpg GRAPHIC 159599
13 nt10013010x5_linechart04.jpg GRAPHIC 152183
14 nt10013010x5_linechart05.jpg GRAPHIC 169814
15 nt10013010x5_linechart06.jpg GRAPHIC 150253
  Complete submission text file 0001140361-20-016369.txt   3213773
Mailing Address WINZERLAER STR. 2 JENA 2M 07745
Business Address WINZERLAER STR. 2 JENA 2M 07745 49 3641 508180
InflaRx N.V. (Filer) CIK: 0001708688 (see all company filings)

IRS No.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-239759 | Film No.: 201035261
SIC: 2834 Pharmaceutical Preparations